| The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study 2016 · GS · Women aged 50–60 years with BMI ≥27 kg/m² and no diagnosis of knee osteoarthritis | 1.5 g | 913 days | 102 |
| The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study 2016 · DEP + GS · Women aged 50–60 years with BMI ≥27 kg/m² and no diagnosis of knee osteoarthritis | 1.5 g | 913 days | 102 |
| Do shrimp-allergic individuals tolerate shrimp-derived glucosamine? 2006 · Shrimp-derived glucosamine · 15 subjects with a history of shrimp allergy, positive shrimp skin tests and shrimp-specific ImmunoCAP class level of two or greater | 1.5 g | 1 day | 15 |
| Do shrimp-allergic individuals tolerate shrimp-derived glucosamine? 2006 · Synthetically produced glucosamine (control) · 15 subjects with a history of shrimp allergy, positive shrimp skin tests and shrimp-specific ImmunoCAP class level of two or greater | 1.5 g | 1 day | 15 |
| Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study 2021 · glucosamine sulfate and chondroitin sulfate (double active) · Adults aged 45–75 with symptomatic knee osteoarthritis | 1.5 g | 2 years | — |
| Glucosamine sulfate in osteoarthritis of the knee 1994 · glucosamine sulfate · outpatients with knee osteoarthritis, radiological stage I–III, Lequesne severity index of at least 4, and symptoms for at least 6 months | 1.5 g | 4 weeks | 120 |
| Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial 2001 · glucosamine sulphate · Patients with knee osteoarthritis; age and sex not specified | 1.5 g | 3 years | 106 |
| Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator 2007 · glucosamine sulfate · Patients with knee osteoarthritis and moderately severe symptoms; age and sex not reported | 1.5 g | 26 weeks | 106 |
| The Efficacy of Piascledine in Alleviating Symptoms and Its Impact on Blood Lipid Levels and body Mass Index in Patients with Knee Osteoarthritis 2024 · Group B (glucosamine sulfate; GCS) · Adults aged over 40 with knee osteoarthritis; men and women | 1.5 g | 8 weeks | 100 |
| Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial 2016 · Glucosamine sulfate plus diacerein · Adults with mild to moderate primary or secondary knee osteoarthritis; age 50 years or older per eligibility criteria; men and women | 1.5 g | 26 weeks | 74 |
| Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial 2016 · Glucosamine sulfate plus placebo · Adults with mild to moderate primary or secondary knee osteoarthritis; age 50 years or older per eligibility criteria; men and women | 1.5 g | 26 weeks | 74 |
| [A multi-central, randomized, controlled clinical trial of glucosamine hydrochloride/sulfate in the treatment of knee osteoarthritis] 2005 · GH group · Patients with knee osteoarthritis; age and sex not reported | 1.44 g | 4 weeks | 71 |
| [A multi-central, randomized, controlled clinical trial of glucosamine hydrochloride/sulfate in the treatment of knee osteoarthritis] 2005 · GS group · Patients with knee osteoarthritis; age and sex not reported | 1.5 g | 4 weeks | 71 |
| Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351] 2007 · Glucosamine · Adults over 20 years of either sex with mild to moderate knee osteoarthritis | 3 g | 8 weeks | 47 |
| Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study 2010 · GS-K group · Adults with symptomatic mild or moderate knee osteoarthritis, Ahlback grades 1–4; age and sex not specified | 1.5 g | 16 weeks | 45 |
| Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study 2010 · GS-Na group · Adults with symptomatic mild or moderate knee osteoarthritis, Ahlback grades 1–4; age and sex not specified | 1.5 g | 16 weeks | 45 |
| The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial 2021 · Group A: HPLT + glucosamine sulfate · Adults aged 45–60 with grade 2 knee osteoarthritis | 1.5 g | 60 days | 45 |
| A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis 2012 · Group A (GS) · Men and women older than 20 years with mild to moderate knee osteoarthritis | 1.5 g | 90 days | 43 |
| Comparison of the symptomatic and chondroprotective effects of glucosamine sulphate and exercise treatments in patients with knee osteoarthritis 2015 · glucosamine sulphate group · patients with knee osteoarthritis; age and sex not reported | 1.5 g | 26 weeks | 40 |
| A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis 2012 · Group B (GS + NSAID) · Men and women older than 20 years with mild to moderate knee osteoarthritis | 1.5 g | 90 days | 39 |
| Randomized, double-blind, four-arm pilot study on the effects of chicken essence and type II collagen hydrolysate on joint, bone, and muscle functions 2023 · Glucosamine HCl · Adults aged 45–75 with mild to moderate knee osteoarthritis and knee pain | 1.5 g | 24 weeks | 38 |
| Effects of glucosamine administration on patients with rheumatoid arthritis 2007 · glucosamine group · Patients with rheumatoid arthritis; age and sex not reported | 1.5 g | 12 weeks | 25 |
| The effect of glucosamine supplementation on people experiencing regular knee pain 2003 · glucosamine group · People with regular knee pain, most likely due to previous articular cartilage damage and possibly osteoarthritis; age and sex not reported | 2 g | 12 weeks | 24 |
| Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip 2012 · diclofenac group (positive control) · Adults with confirmed knee or hip osteoarthritis; ages not reported; 18 women and 4 men | 1 g | 4 weeks | 22 |
| Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month clinical trial 2001 · GS · Women and men with temporomandibular joint osteoarthritis | 1.5 g | 90 days | 21 |
| Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial 2010 · Three-day walking group · Adults aged 40–75 with physician-diagnosed hip or knee osteoarthritis | 1.5 g | 18 weeks | 19 |
| Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial 2015 · group A · Patients with moderate to severe atopic dermatitis and SCORAD index ≥30; age and sex not reported | 25 mg/kg | 8 weeks | 19 |
| Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial 2010 · Five-day walking group · Adults aged 40–75 with physician-diagnosed hip or knee osteoarthritis | 1.5 g | 18 weeks | 17 |
| Impact of Glucosamine Supplementation on Gut Health 2021 · glucosamine condition (GLU) · Healthy men and women aged 18–50 years | 3 g | 3 weeks | 11 |
| Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee 1994 · glucosamine sulfate group · Hospitalized patients with active knee osteoarthritis, symptoms for at least 3 months, and Lequesne's index of at least 7 points; age and sex not reported | 1.5 g | 4 weeks | — |
| Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study 2002 · glucosamine sulfate · Patients with mild-to-moderate knee osteoarthritis | 1.5 g | 3 years | — |
| Potential effects of chondroitin sulfate on joint swelling: a GAIT report 2008 · glucosamine · Adults with symptomatic, radiographic knee osteoarthritis | 1.5 g | 24 weeks | — |
| Efficacy and tolerance of enzymatic hydrolysed collagen (EHC) vs. glucosamine sulphate (GS) in the treatment of knee osteoarthritis (KOA) 2011 · glucosamine sulphate (GS) · Men and women aged 40 years or older with knee osteoarthritis | 1.5 g | 90 days | — |
| Kashin-Beck disease in Sichuan, China: report of a pilot open therapeutic trial 2012 · glucosamine hydrochloride group · Adults with symptomatic Kashin-Beck disease | 1.5 g | 6 weeks | — |
| Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial 2013 · Glucosamine sulphate alone · Patients with primary knee osteoarthritis; adult age range and sex distribution by arm not reported | 1.5 g | 6 weeks | — |
| Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial 2013 · glucosamine · Patients with symptomatic knee osteoarthritis; age and sex not specified | 2 g | 24 weeks | — |
| Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial 2016 · GS group · People with knee arthritis; age and sex not reported | 1.5 g | 60 days | — |
| Mineral rich algae with pine bark improved pain, physical function and analgesic use in mild-knee joint osteoarthritis, compared to Glucosamine: A randomized controlled pilot trial 2020 · Glu group · Participants with symptomatic knee osteoarthritis; age and sex not specified | 2 g | 12 weeks | — |
| Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis 1998 · glucosamine sulfate group · Chinese patients with knee osteoarthritis; age and sex not reported | 1.5 g | 4 weeks | — |
| Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis 2015 · GIII · Adults with radiographic knee osteoarthritis, Kellgren/Lawrence grade 2–3; age and sex not specified | 1.5 g | 16 weeks | 306 |
| Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis 2015 · GI · Adults with radiographic knee osteoarthritis, Kellgren/Lawrence grade 2–3; age and sex not specified | 1.5 g | 16 weeks | 302 |
| Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices 2023 · Control group · Adults aged 65–85 with knee osteoarthritis in one knee | 1.5 g | 5 weeks | 146 |
| Alga Ecklonia bicyclis, Tribulus terrestris, and glucosamine oligosaccharide improve erectile function, sexual quality of life, and ejaculation function in patients with moderate mild-moderate erectile dysfunction: a prospective, randomized, placebo-controlled, single-blinded study 2014 · Group A · Men aged 18–75 with mild-to-moderate nonendocrinological erectile dysfunction | 500 mg | 90 days | 87 |
| Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study 2016 · GC group · Men and women aged 40–75 with moderate-to-severe knee osteoarthritis | 1.5 g | 180 days | 66 |
| Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial 2018 · GC Group · Males and females aged 40–75 years with mild to moderate knee osteoarthritis | 750 mg | 180 days | 61 |
| Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial 2016 · Glu/Cho group · Japanese adults aged 52–87 with knee pain and/or stiffness | 100 mg | 24 weeks | 50 |
| Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial 2017 · GCM · Patients with Kellgren-Lawrence grade I-II knee osteoarthritis; age and sex not specified | 1.5 g | 90 days | 50 |
| Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial 2017 · GC · Patients with Kellgren-Lawrence grade I-II knee osteoarthritis; age and sex not specified | 1.5 g | 90 days | 49 |
| Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial 2009 · Glucosamine HCl plus chondroitin sulfate group (G+C) · Adults with moderate to severe osteoarthritis of the knee; age and sex distribution not specified for this arm. | 750 mg | 90 days | 26 |
| The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial 2021 · A+HA group · Men and women aged 40 years or older with knee osteoarthritis and mild knee pain | 750 mg | 8 weeks | 24 |
| Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip 2012 · ginger group · Adults with confirmed knee or hip osteoarthritis; ages not reported; 17 women and 4 men | 1 g | 4 weeks | 21 |
| A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study 2001 · active medication group · People diagnosed with capsulitis, disk displacement, disk dislocation, or painful osteoarthritis of the temporomandibular joint | 1.5 g | 12 weeks | 14 |
| [Glucosamine hydrochloride combined with hyaluronate for temporomandibular joint osteoarthritis: a primary report of randomized controlled trial] 2011 · Intervention group · People with temporomandibular joint osteoarthritis | 1.44 g | 4 weeks | 14 |
| Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis 2000 · intervention group · Adults with knee osteoarthritis; age and sex not reported | 2 g | 26 weeks | — |
| Potential effects of chondroitin sulfate on joint swelling: a GAIT report 2008 · glucosamine plus chondroitin sulfate · Adults with symptomatic, radiographic knee osteoarthritis | 1.5 g | 24 weeks | — |
| Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study 2012 · GCQ supplement · Japanese subjects with symptomatic knee osteoarthritis | 1.2 g | 16 weeks | — |
| Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial 2013 · NR-INF-02 and GS combination · Patients with primary knee osteoarthritis; adult age range and sex distribution by arm not reported | 1.5 g | 6 weeks | — |
| Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial 2018 · group A · people with temporomandibular joint osteoarthritis | 1.44 g | 90 days | — |
| Curcumagalactomannoside/Glucosamine Combination Improved Joint Health Among Osteoarthritic Subjects as Compared to Chondroitin Sulfate/Glucosamine: Double-Blinded, Randomized Controlled Study 2020 · Group I (CGM-GLN) · Adults with confirmed class I–III osteoarthritis; ages not reported; 38 males and 42 females across both groups | 1 g | 12 weeks | — |
| Curcumagalactomannoside/Glucosamine Combination Improved Joint Health Among Osteoarthritic Subjects as Compared to Chondroitin Sulfate/Glucosamine: Double-Blinded, Randomized Controlled Study 2020 · Group II (CHN-GLN) · Adults with confirmed class I–III osteoarthritis; ages not reported; 38 males and 42 females across both groups | 1 g | 12 weeks | — |
| Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial 2021 · GS/CS group · Patients with knee osteoarthritis, Kellgren-Lawrence grades 2 or 3, with a mean WOMAC pain subscale score of at least 40 mm | 1.5 g | 24 weeks | — |
| Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study 2015 · GCQID group · Japanese women and men aged 40–74 years with knee pain | 1.2 g | 16 weeks | 50 |
| A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial 2013 · Instaflex · Men and women aged 50–75 with self-reported joint pain lasting more than 3 months | 1.5 g | 8 weeks | 49 |
| A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study 2024 · supplement group · Adults with symptomatic MRI-confirmed lumbar osteochondrosis; age range and sex not specified | 200 mg | 90 days | 26 |
| Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study 1999 · combination therapy · male U.S. Navy diving and special warfare personnel with chronic pain and radiographic degenerative joint disease of the knee or low back | 1.5 g | 16 weeks | — |
| Comparative bioavailability of a novel timed release and powder-filled glucosamine sulfate formulation--a multi-dose, randomized, crossover study 2004 · Timed release glucosamine sulfate (TimeOsamine) · 12 healthy male subjects | 1 g | 1 day | 12 |
| Comparative bioavailability of a novel timed release and powder-filled glucosamine sulfate formulation--a multi-dose, randomized, crossover study 2004 · Powder-filled glucosamine sulfate formulation · 12 healthy male subjects | 1.5 g | 1 day | 12 |
| Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man 2005 · 750 mg dose · Healthy volunteers; sex and age range not specified | 750 mg | 3 days | 12 |
| Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man 2005 · 1,500 mg dose · Healthy volunteers; sex and age range not specified | 1.5 g | 3 days | 12 |
| Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man 2005 · 3,000 mg dose · Healthy volunteers; sex and age range not specified | 3 g | 3 days | 12 |
| Pharmacokinetic Comparison of Chitosan-Derived and Biofermentation-Derived Glucosamine in Nutritional Supplement for Bone Health 2022 · Bio-fermented glucosamine sulfate 2KCL · Healthy adult males and females | 1.5 g | 1 day | 10 |
| Pharmacokinetic Comparison of Chitosan-Derived and Biofermentation-Derived Glucosamine in Nutritional Supplement for Bone Health 2022 · Chitosan-derived glucosamine sulfate 2KCL · Healthy adult males and females | 1.5 g | 1 day | 10 |
| Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis 1996 · NAG · 10 healthy subjects; age and sex not reported | 1 g | 3 days | 10 |
| Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis 1996 · POLY-Nag · 10 healthy subjects; age and sex not reported | 1 g | 3 days | 10 |
| Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens 2015 · glucosamine sulfate · Adults aged 45–75 with chronic knee pain and medial tibio-femoral compartment narrowing consistent with symptomatic knee osteoarthritis | 1.5 g | 2 years | 152 |
| Evaluation of the effect of the administration of a glucosamine‑containing supplement on biomarkers for cartilage metabolism in soccer players: A randomized double‑blind placebo‑controlled study 2018 · glucosamine group · Collegiate soccer players without joint disorders; age and sex not specified | 2 g | 16 weeks | 22 |
| Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles 2013 · Glucosamine sulphate group · People diagnosed with knee osteoarthritis; age and sex not reported | 3 g | 12 weeks | — |
| Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens 2015 · glucosamine-chondroitin combination · Adults aged 45–75 with chronic knee pain and medial tibio-femoral compartment narrowing consistent with symptomatic knee osteoarthritis | 1.5 g | 2 years | 151 |
| Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients 2020 · Combined glucosamine hydrochloride plus chondroitin sulfate (GH+CS) · Patients with knee osteoarthritis; age and sex not specified | 1.5 g | 26 weeks | 96 |
| Effects of Arctium lappa L. (Burdock) root tea on inflammatory status and oxidative stress in patients with knee osteoarthritis 2016 · Intervention group · Men and women aged 50–70 years with knee osteoarthritis | 500 mg | 6 weeks | 18 |
| Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans 2015 · Glucosamine and chondroitin (G&C) intervention · Healthy, overweight, non-smoking men and women aged 20–55 years | 1.5 g | 4 weeks | 18 |
| Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint 2015 · study group · Women aged 18–40 with internal derangement of the temporomandibular joint, pain lasting longer than 4 weeks, and limitation in mouth opening | 1.5 g | 8 weeks | — |
| Effects of 4-month treatment with glycocalyx dietary supplement on endothelial glycocalyx and vascular function after COVID-19 infection 2025 · GDS · Adults aged 18–75 with mild-to-moderate COVID-19 infection managed as outpatients | 750 mg | 120 days | 29 |
| Effects of Arctium lappa L. (Burdock) root tea on inflammatory status and oxidative stress in patients with knee osteoarthritis 2016 · Control group · Men and women aged 50–70 years with knee osteoarthritis | 500 mg | 6 weeks | 18 |
| Influence of a low-dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open-labeled, active-controlled clinical trial 2021 · GLN-CHN combination group · Adults with knee osteoarthritis | 1 g | 6 weeks | — |